BRIEF

on Cherry SE (isin : DE000A3CRRN9)

Cherry SE Achieves Key Milestone with SmartLink Approval

Munich, October 21, 2024 - Cherry SE's subsidiary, CHERRY Digital Health, has received official product approval from gematik for its eHealth-CardLink, part of the SmartLink solution. This technology allows secure e-prescription redemption via NFC-enabled smartphones. Users can order prescriptions online or reserve them at pharmacies using their electronic health card.

This approval strengthens CHERRY Digital Health's position in the digital healthcare sector. According to Managing Director Gerrit Schick, it signifies a significant vote of confidence in CHERRY's quality and security.

Oliver Kaltner, CEO of Cherry SE, acknowledges Germany's lag in digitalization, especially in healthcare, emphasizing the industry's role in driving change. CHERRY collaborates with Awesome Technologies on innovative solutions like the TI Messenger for secure, real-time communication among healthcare stakeholders in Germany.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Cherry SE news